More specifically, we were able to replicate the associations between the use of TNF-α inhibitors and78 methotrexate79 and reduced risk of Alzheimer’s disease and to provide evidence of the potential benefits of methotrexate in Parkinson’s disease. The gene discussed is TNF; the disease is early-onset autosomal dominant Alzheimer disease.